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ABSTRACT  
AIMS: Virtual microscopy utilising digital whole slide imaging (WSI) is increasingly used in breast 
pathology. Histologic grade is one of the strongest prognostic factors in breast cancer (BC). This study 
aims at investigating the agreement between BC grading using traditional light microscopy (LM) and 
digital whole slide imaging (WSI) with consideration of reproducibility and impact on outcome 
prediction.  
METHODS: A large (n=1675) well-characterised cohort of BC originally graded by LM was re-graded 
using WSI. Two separate virtual-based grading sessions (V1 and V2) were performed with a three months 
washout period. Outcome was assessed using breast cancer specific and distant metastasis free survival. 
RESULTS: The concordance between LM grading and WSI was strong (LM/SWI Cramer’s V: 
V1=0.576, and V2=0.579). The agreement regarding grade components was as follows: Tubule 
formation=0.538, Pleomorphism=0.422 and Mitosis=0.514.  Greatest discordance was observed between 
adjacent grades whereas high/low grade discordance was uncommon (1.5%).  The intra-observer 
agreement for the two WSI sessions was substantial for grade (V1/V2 Cramer’s V=0.676; kappa=0.648) 
and grade components (Cramer’s V T=0.628, P=0.573 and M=0.580). Grading using both platforms 
showed strong association with outcome (All p-value <0.001). Although mitotic scores assessed using 
both platforms were strongly associated with outcome, WSI tends to underestimate mitotic counts.    
CONCLUSIONS: Virtual microscopy is a reliable and reproducible method for assessing BC histologic 
grade. Regardless of the observer or assessment platform, histologic grade is a significant predictor of 
outcome.  Continuing advances in imaging technology could potentially provide improved performance 
of WSI BC grading and in particular mitotic count assessment. 
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INTRODUCTION 
Virtual microscopy (VM) using digital whole slide imaging (WSI) is a technology through which glass 
slides of pathologic specimens are digitally scanned at high-resolution for viewing on a computer screen. 
Applications of WSI in the clinical, educational, and research settings including image analysis 
applications are increasing and in some centres WSI has replaced conventional microscopy as a 
diagnostic tool used by pathologists 1-6. However, one of main the concerns related to VM adoption in 
breast pathology, in addition to diagnosis, is the assessment of prognostic and predictive variables 
including histologic grade 6. There is a perception that the quality of the images displayed by WSI may 
interfere with reliable histologic grading. In addition the interpretive ability of the reporting Pathologist 
assigning a “virtual grade” to each cancer remains largely unknown.  
Therefore, to improve WSI performance, enhancement of the WSI platform and the training of 
histopathologists with the digital environment is recommended. However, testing performance and 
reproducibility of WSI in cases’ reporting is critically needed. This could be achieved via head-to-head 
comparison of WSI compared to traditional light microscopy (LM) to provide sufficient evidence prior 
to clinical adoption.   
Grading of breast cancer using the Nottingham combined histologic grade is one of the strongest 
prognostic factors in early stage disease 7-9. Grade comprises one of the main components of several 
management decision tools 10-13 and it has recently been included in the American Joint Committee on 
cancer (AJCC) TNM staging system as a stage modifier 14,15. However concordance of breast cancer 
grading among pathologists using glass slides shows moderate agreement with kappa values of 0.48 16 
to 0.53 17; the high concordance rates observed in grade 3 (kappa 0.60) and grade 1 (kappa 0.51) tumours 
whereas the lowest is observed with grade 2 (kappa 0.33) tumours 16. The impact of introduction of WSI 
in routine practice on the concordance of grade and its performance as a prognostic factor remains to be 
defined.  
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Therefore, this study aims at comparing the histologic grading of breast cancers as assigned by an expert 
pathologist using WSI with the grade assessed in routine practice using LM. In addition to assessment of 
concordance, impact of different grading platforms on patient outcome was evaluated using the large 
well characterised Nottingham breast cancer cohort.  
 
PATIENTS AND METHODS 
This study has been performed on a large series (n=1675) of early stage invasive primary operable breast 
cancer patients presented to Nottingham City Hospital from 1999-2006. This is a well-characterised 
cohort of breast cancer with long term clinical follow-up (median 135 months) and detailed clinico-
pathological profiles. Data included primary tumour histologic grade and grade components, tumour size 
and histotype, lymph node stage, nodal status, lymphovascular invasion, Nottingham Prognostic Index, 
molecular subtypes and outcome data was collected. The latter include breast cancer-specific survival 
(BCSS), defined as time (in months) from the date the primary surgical treatment to the time of death 
from breast cancer, and distant metastasis free survival (DMFS) was defined as the time (in months) from 
the surgery until the first event of distant metastasis. Patient and tumour demographics are summarised 
in Table 1.  
This tumour cohort was originally graded using the Nottingham grading system during routine pathology 
reporting utilising all available tumour glass slides (average 4 slides per case) and light microscopy (LM) 
8. For the purpose of this study, data for the final grade as well as the individual grade components (tubule 
formation, nuclear pleomorphism and mitotic count scores) was retrieved from the patients’ records.  1-
3 tumour blocks per case were retrieved and freshly prepared H&E slides were reviewed. A 
representative slide per case was selected by a specialised breast pathologist (EA Rakha) without further 
glass slide grading. Glass slides were scanned into high-resolution (0.19 μm/pixel) digital images at 20x 
magnification using 3D Histech Panoramic 250 Flash II scanner (3DHISTECH Ltd., Budapest, 
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Hungary). The whole slide digital images (WSI) were generated, stored and viewed using the 3D Histech 
Pannoramic Viewer (3DHISTECH Ltd., Budapest, Hungary; http://www.3dhistech.com/downloads) on 
a high resolution screen. The digital slide was graded using College of American Pathologists’ criteria 18 
which are essentially the same as the original Nottingham criteria 7. Digital images were initially 
examined at low magnification where tubule formation was assessed. Also, low to intermediate 
magnification was performed for the identification of potential “hotspots” for mitotic counting. 
Essentially, for mitotic counting, the distance measure tool of the software was used. This was important 
for determining the number of mitotic figures in a given area.  
To allow for intra-observer agreement of BC grading using WSI, the whole cohort was graded again by 
the same observer (Dr L. Dalton who is an experienced breast pathologists with special interest in breast 
cancer grading) using the same criteria twice after a 3-month washout time with no special training during 
that time. In both WSI grading sessions (V1 and V2), grade components were assigned blinded to the 
LM grade as well as other clinicopathological parameters.  
This study was approved by Nottingham Research Ethics Committee 2 under the title of “Development 
of a molecular genetic classification of breast cancer”. 
 
Statistical analysis 
Statistical analysis was performed using functions obtained from the open-source R statistical platform 
19. Since WSI and LM have a procedural difference, Cramer's V statistic was adopted to help judge 
strength of concordance 20. The coefficient ranges from 0 (no association) to 1 (perfect association). The 
kappa statistic is technically a measure of concordance between two observers who are examining the 
same parameter following the same approach 21.  For these analyses, R library vcd had the function 
required for calculating the Cramer's V statistic (= function assocstats), while the function for kappa 
statistic was obtained from R library inter-rater reliability. Survival analysis was performed using SPSS 
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23 (SPSS 23 for Windows, Chicago, IL, USA) using log rank test and Kaplan Meier plots. Survival 
analysis (BCSS and DMFS) was performed on WSI grade as well as the WSI component scores. 
Likewise, survival analysis was performed for the glass-slide LM grade to include separate analysis of 
the component scores. Multivariate analysis was performed using cox proportional hazards analysis with 
inclusion of parameters significantly associated with outcome in univariate analysis. Statistical 
significance in survival stratification was calculated by the log-rank method and univariate cox regression 
analysis. A p-value of less than 0.05 (two tailed) was considered significant. 
 
RESULTS 
In this study, a large 1675 retrospective cohort of early invasive primary operable BC were graded on 
high-resolution digital images acquired through WSI of representative slides. For this WSI grading, as 
for the original LM, the three-tier histologic grade of BC was used 7,8,18. Tables 2 and 3 show cross 
comparison of WSI grade with LM grade as well as the cross comparison of the three components of the 
Nottingham grade. Table 4 shows the cross comparison of the sum of grade components (3-9 scale) for 
LM grade scores and WSI grade scores. 
The agreement between WSI grading and glass slide/LM grading was moderate for the both WSI grading 
sessions when kappa statistic was used (V1/LM kappa=0.51, and V2/LM kappa=0.50). However, when 
Cramer’s V statistic was used the Cramer’s V for WSI with LM was 0.58 in both sessions respectively 
which is considered as a substantial concordance. If grade is reduced to a binary level of high (i.e. grade 
3) versus not high (i.e. grade 1 &2), the Cramer's V was 0.66. The unweighted kappa statistic for WSI 
grade with LM grade was 0.51.  The kappa statistics for component scores were: mitoses = 0.47; tubules 
= 0.49; and pleomorphism = 0.3. 
Importantly, exact grade agreement between WSI and LM grading was reached in 68% of cancers.  There 
was almost an even match in the number of cancers with low-intermediate discordance (255 cancers; 
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15.1%) as compared to intermediate-high discordance (265 cancers; 15.7%). There was 32.3% 
discordance between WSI and LM grade, which is largely between adjacent levels of grade: low versus 
intermediate, or intermediate versus high grade. The binary high versus low/intermediate discordance of 
grade was 17%. In this study only twenty-six (1.5%) grade assignments were attributable to high versus 
low-grade discrepancy and the proportion reduction of high in LM to low in WSI was highly significant 
(p< 0.00001). 
The intra-observer agreement for the two virtual sessions (V1/V2) was higher than the values of 
agreement between WSI and LM but remained in the moderate concordance category (table 5).   
  
Survival analysis 
Survival analysis was performed on both the grade assigned by WSI and the original LM, Table 5. WSI 
grading in both grading sessions showed statistically significant differences for BCSS and DMFS as did 
the LM grading (p = 1x10-13) (table 6). Individual WSI grade components showed statistically significant 
differences for BCSS and DMFS. WSI tubule formation showed a stronger association with BCSS than 
that of LM (Hazards ratio (HR)=2.8, 95%CI=1.9-4.0, and 1.9, 95%CI=1.5-2.4, for WSI and LM 
respectively). Similar results were observed for DMFS (HR=2.6, 95% CI=1.9-3.6, and 1.7 95%CI= 1.4-
2.1). Figures1 and 2 show survival curves of the final WSI and LM based histologic grade as well as 
grade components and BCSS.  
To assess the prognostic independency of BC grade assigned using LM and WSI V1 and V2 multivariate 
analyses were performed including other established prognostic variables in the models. LM grading as 
well as WSI V1 and V2 were significantly associated with BCSS (p value for the 3 grading methods were 
< 0.001) and DMFS ((p value < 0.001), independent of other variables, Table 7.   
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DISCUSSION 
Currently, there is an increasing interest in using WSI for diagnostic and research purposes. However, it 
is crucial to ensure that diagnostic performance utilising virtual slides is at least equivalent to that of 
using conventional light microscopy. To validate the diagnostic concordance of WSI and LM, USCAP 
recommends 12 rigorously developed guidelines with the potential of providing pathology laboratories 
with a practical guide to validate WSI systems for diagnostic work 22. These include, yet not limited to 
the number required for double reporting (at least 60 cases per application) and the washout period (at 
least 2 weeks). In the current study, more than 1600 breast cancers were regraded using WSI by expert 
pathologists and the results were compared to the original routine practice generated grade.  The 
quantifiable three-tier system of Nottingham grade compiling the degree of tubule formation, nuclear 
pleomorphism and mitotic frequency scores, is an ideal parameter for comparing WSI with LM. To assess 
the intra-observer concordance and the impact of WSI training on, the whole cohort was grading again 
with a long washout interval of 3 months. The end-point for this study was the concordance statistics as 
well as the patients’ clinical outcome.  To the best of our knowledge, this is the largest study performing 
head-to-head comparison of breast cancer grading using WSI and LM including patients’ survival as a 
study endpoint.  
WSI grading showed moderate concordance with LM grading comparable to concordance rate reported 
among different pathologists who graded breast cancer using conventional microscopy 16,17 . Exact grade 
agreement between WSI and LM grading was reached in 68% of cases. This magnitude of concordance 
is in-line with a prior reproducibility study 23.  Since WSI has a procedural difference, compared with 
LM, some emphasis was given to Cramer’s V as measure of concordance. Multiple authorities considered 
a Cramer’s V of a value greater than 0.5 to be the break point for acceptable concordance 24,25. In the 
current study, WSI grade as compared to LM grade had Cramer's V of 0.58 at the ternary level and 0.66 
at a binary level. These figures indicate high levels of reproducibility and demonstrate WSI reliability as 
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a platform for grading breast cancer taking into account the inherent discordance levels in grade 
assignment between different observers using a single platform. Detailed analysis of discordance at the 
level of individual cases awaits further study, to include evaluation by recently introduced technologies. 
In this study, the true merit of WSI as compared to LM was further studied as regard to whether both 
offered a comparable level of patients’ survival stratification utilising the large number of cases with 
long-term follow-up data. Both WSI and LM showed significant association with patients’ outcome as 
well the individual grade components assessed by both platforms. Interestingly, tubule formation as 
assessed by WSI showed stronger association with outcome compared VLM assessment. Of note our 
study demonstrated that morphology is easy enough to be amendable to survival analysis while 
technically difficult molecular assays are not 26,27.  
The intra-observer agreement for the two WSI sessions was moderate and showed similar association 
with outcome. These results support the fact that the level of concordance is to a large extent related to 
observer performance and the subjective nature of grade rather than the platform used. This together with 
the limitation of the current study which include 1) grade was assessed by different observers, 2) original 
grade was assessed using an average of four tumour tissue slides per case whereas WSI grade was 
assessed on a single slide, and 3) WSI scan magnification used was 20x rather than 40x which is 
considered ideal for assessment of mitotic counts. In fact, among the three Nottingham grade 
components, the most challenging component to evaluate by WSI was mitotic counts.  There was 
difficulty in discerning mitotic figures from apoptotic cells. Although this was largely attributed to 
resolution, the inability of WSI to provide different planes may have contributed as an additional hurdle. 
Therefore, assessment of mitotic counts using 40x magnification may help resolving this issue. However, 
the large number of cases in this study and the repeated grade by the same observer using WSI has 
potentially overcome these limitations. The reasons for the tendency of lower mitotic scores in WSI 
compared to LM are likely related to the use of a single slide per case and the lower magnification used 
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in WSI.  
In breast cancer grading there will be, without doubt, some discordance between grade assignments by 
WSI as well as to LM grading. Also, comparisons among biomarkers tested for diagnostic and research 
purposes share this possibility of discordance 25,26,28. However, at the level of an individual patient 
especially in the diagnostic setting, discordance is usually met with caution and concordance is sought 
for. Therefore, sustained effort is critically needed for improvement in concordance, or at least for an 
improved understanding in the meaning of discordance. In the current study, grading was validated as a 
ternary scheme and as binary scheme to assess for concordance of both grading platforms. Previous 
studies addressing binary biomarkers have compared their results with grade by collapsing grade into a 
binary scheme. For illustrative purposes, we did the same, and showed strong concordance of WSI with 
LM, no matter if low and intermediate grade were combined, or intermediate with high grade; 
concordance of grade was Cramer’s V= 0.55 if low combined with intermediate. 
As mentioned above two reasons are thought to be responsible for underperforming of WSI in the 
assessment of histologic grade which are the technology itself or WSI and the reader. This study 
demonstrates that grading using WSI is not only reproducible but also provides significant survival 
information comparable to glass slides. The concordance rate between glass slides grading and WSI was 
comparable to these reported using glass slides as the only tool and the intra-observer concordance using 
WSI was even higher than that reported by multiple readers using glass slides 29,30.  This study in addition 
to providing evidence for the reproducibility and reliability of WSI in grading breast cancer could prompt 
the question of what would be the minimal number of cases, randomly selected, which would be expected 
to show if a histopathologist would show ability to predict survival using WSI grade. If low enough then 
WSI may be a method to test competence at the level of survival prediction and not just concordance. 
The use of WSI technology also opens up opportunities for computer assisted classification of histologic 
grade with inherent improved standardisation and reproducibility of evaluation and potential for 
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refinement of methodology. 
 
Take home messages 
- Regardless of the observer or assessment platform, histologic grade is a significant predictor of 
outcome.  
 
- Virtual microscopy is a reliable and reproducible method for assessing breast cancer histologic grade.  
 
- Higher magnification (x40) is recommended to produce adequate resolution for an accurate grading 
 
- Continuing advances in imaging technology could potentially provide improved performance of 
whole slide imaging breast cancer grading and in particular mitotic count assessment. 
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Tables 
Table 1: Characteristics of the breast cancer cohort 
Parameters Number of cases (%) 
Age 
  >50 
  ≤50 
  Unknown 
 
1098 (65.6)  
549 (32.8) 
28 (1.7) 
Tumour size  
  > 2.0cm 
  ≤2.0cm 
  Unknown 
 
588 (35.1)  
1058 (63.2) 
29 (1.7) 
Lympho-vascular Invasion 
  Negative 
  Positive 
  Unknown 
 
1197 (71.5)  
450 (26.9) 
28 (1.7) 
Lymph node status  
  Negative  
  Positive  
  Unknown 
 
1132 (67.6) 
515 (30.7) 
28 (1.7) 
Lymph Node Stage 
  1 
  2 
  3 
Unknown 
 
1027 (62.4)  
457 (27.3)  
162 (9.7) 
29 (1.7) 
Nottingham Prognostic Index  
  Good  
  Moderate  
  Poor 
  Unknown 
 
568 (33.9)  
820 (49)  
256 (15.3) 
31 (1.9) 
Histologic types 
  Ductal NST  
  Lobular  
  Tubular/Invasive Cribriform 
  Pure Mucinous  
  Invasive Micropapillary  
  Other types including Medullary-like  
 
1258 (75.1)  
102 (6.1)  
60 (3.6) 
22 (1.3)  
13 (0.8)  
220 (13.1) 
Distant metastasis  
  Yes  
  No  
  Unknown 
 
357 (21.3)  
1288 (76.9)  
30 (1.6) 
Outcome Status at end of follow-up  
  Alive  
  Died from Breast cancer  
  Died from other causes  
  Unknown 
 
1190 (71)  
297 (17.7)  
156 (9.3)  
32 (1.9) 
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Table 2: Cross comparison of Nottingham grade (2a) and grade component scores (2b-d) between 
virtual microscopy and traditional light microscopy  
Table 2a 
Grade  
(Virtual Microscopy)  
Grade (Light Microscopy)  
Total percentage 
Grade 1 Grade 2 Grade 3 
  Grade 1  232 215 25 28.2% 
  Grade 2 39 420 213 40.1% 
  Grade 3 1 48 482 31.7% 
Total Percentage 16.2% 40.8% 43% 100% 
Percent exact agreement: 68%, Percent adjacent level: 30.5%, Percent high/low: 1.5% 
 
Table 2b 
Tubule formation  
(Virtual Microscopy)  
Tubule formation (Light Microscopy)  
Total percentage 
Score 1 Score 2 Score 3 
  Score 1  43 13 2 3.5% 
  Score 2 67 231 34 19.8% 
  Score 3 12 265 1008 76.7% 
Total Percentage 7.3% 30.4% 62.3% 100% 
Percent exact agreement: 76.6%, Percent adjacent level: 22.6%, Percent high/low: 0.8% 
 
Table 2c 
Pleomorphism  
(Virtual Microscopy) 
Pleomorphism (Light Microscope)  
Total Percentage Score 1 Score 2 Score 3 
  Score 1  18 210 69 17.7% 
  Score 2 6 250 336 35.3% 
  Score 3 0 48 738 46.9% 
Total Percentage 1.4% 30.3% 68.3% 100% 
Percent exact agreement: 60.1%, Percent adjacent level: 35.8%, Percent hi/low: 4.1% 
 
Table 2d 
Mitotic counts 
(Virtual Microscopy) 
Mitotic counts (Light Microscope)  
Total Percentage Score 1 Score 2 Score 3 
  Score 1  807 187 102 65.4% 
  Score 2 34 75 136 14.7% 
  Score 3 5 49 280 19.9% 
Total Percentage 50.5% 18.6% 30.9% 100% 
Percent exact agreement: 69.4%, Percent adjacent level: 24.3%, Percent hi/low: 6.3% 
*First Virtual scores (V1) were used here  
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Table 3: Concordance between light microscopy grade and its component scores with virtual 
microscopy grade and its component scores assessed using Cramer’s V and kappa statistic. 
 
Parameters 
Cramer's V statistic kappa statistic 
Cramer’s V Phi Kappa  Confidence Interval Z-value 
Grade 0.58 0.82 0.51 0.47 – 0.54 28.4 
Mitosis scores  0.51 0.73 0.46 0.43 – 0.50 25.6 
Tubules scores 0.53 0.75 0.48 0.44 – 0.52 23.1 
Pleomorphism 
scores 
0.41 0.58 0.27 0.24 – 0.31 14.1 
 
Table 4: Cross comparison of the sum of grade components between virtual microscopy and light 
microscopy 
Virtual 
Microscopy 
Light Microscopy  
Total 
3 4 5 6 7 8 9 
Score 3 7 26 5 3 1 0 0 42 
Score 4 8 81 15 22 4 1 2 133 
Score 5 7 88 86 74 19 14 9 297 
Score 6 1 23 126 156 16 41 44 407 
Score 7 0 9 22 88 17 72 57 265 
Score 8 0 1 0 25 11 56 122 215 
Score 9 0 0 3 1 5 43 264 316 
Total* 23 228 257 369 73 227 498 1675 
*p<0.00001 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
Table 5: Concordance of virtual microscopy grade and its component scores between first and second 
session of virtual scoring (intra-observer agreement of grade using virtual microscopy) 
Parameters 
Cramer's V statistic kappa statistic 
Cramer’s V Phi Kappa  Confidence Interval Z-value 
Grade 0.68 0.96 0.65 0.60-0.68 37.3 
Mitosis scores  0.58 0.82 0.60 0.56-0.63 32.7 
Tubules scores 0.63 0.89 0.64 0.60-0.68 29.9 
Pleomorphism 
scores 
0.57 0.81 0.56 0.52-0.59 30.4 
 
 
Table 6: Association between outcome, in terms of breast cancer specific survival (BCSS) and distant 
metastasis free survival (DMFS), and histologic grade; as assessed by virtual microscopy (VM) and 
light microscopy (LM) 
Parameter 
BCSS DMFI  
VM grading LM grading VM grading  LM grading 
HR 
(95%CI) 
p-value  HR 
(95%CI) 
p-value  HR 
(95%CI) 
p-value  HR 
(95%CI) 
p-value  
Grade* 1.9 (1.6-2.3) 1x10-13 2.4 (2.0-3.0) 1x10-13 1.8 (1.5-2.1) 1x10-13 2.1 (1.8-2.5) 1.x10-13 
Tubules * 2.8 (1.9-4) 5.9x10-9 1.9 (1.5-2.4) 9.58x10-
9 
2.6 (1.9-3.6) 4.9 x10-
10 
1.7 (1.4-2.1) 4.6x10-
8 
Pleomorphism* 1.8 (1.5-2.2) 6.2x10-
11 
2.7 (2-3.7) 1x10-10 1.6 (1.3-1.8) 1.6x10-9 2.2 (1.7-2.9) 6.1x10-
10 
Mitosis* 1.5 (1.3-1.7) 2.5x10-
11 
1.7 (1.5-1.9) 1x10-13 1.4 (1.3-1.6) 9.1x10-
11 
1.6 (1.4-1.8) 1.0x10-
13 
         
Grade** 1.9 (1.6-2.3) 1x10-13   1.8 (1.5-2.1) 1.0x10-
13 
  
Tubules** 2.2 (1.6-2.9) 1.32x10-
8 
  2.1 (1.6-2.6) 3.6x10-9   
Pleomorphism** 1.8 (1.5-2.2) 3.9x10-
10 
  1.6 (1.3-1.9) 7.42x10-
9 
  
Mitosis** 1.8 (1.5-2.2) 2.7x10-
10 
  1.4 (1.2-1.6) 2.2x10-9   
* VM grading first session (November 2016). 
** VM grading second session (February 2017). 
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Table 7: Multivariate Cox proportional hazard analysis for predictors of breast cancer specific survival 
(BCSS) and distant metastasis free survival (DMFS) for histologic grade; as assessed by light 
microscopy and virtual microscopy sessions 1 and 2.  
Variables  
BCSS DMFS 
p-value HR (95%CI) p-value HR (95%CI) 
Light Microscopy  
Grade  < 0.001 1.9 (1.5- 2.3) < 0.001 1.6 (1.4 – 2.0) 
Size  0.004 1.4 (1.1- 1.8) < 0.001 1.6 (1.3 – 2.0) 
Nodal Stage < 0.001 2.1 (1.5- 2.3) < 0.001 2.0 (1.8 – 2.4) 
ER status  0.002   0.7 (0.5- 0.9) 0.024 0.7 (0.6 – 0.9) 
Virtual Microscopy 1 
Grade  < 0.001 1.7 (1.4- 2.0) < 0.001 1.6 (1.3 – 1.8) 
Size  0.002 1.5 (1.2- 1.9) < 0.001 1.6 (1.3 – 2.0) 
Nodal Stage < 0.001 2.2 (2.0- 2.6) < 0.001 2.1 (1.9 – 2.5) 
ER status  0.010 0.7 (0.5- 0.9) 0.102 0.8 (0.6 – 1.0) 
Virtual Microscopy 2 
Grade  < 0.001 1.7 (1.4- 2.0) < 0.001 1.6 (1.3 – 1.8) 
Size  0.005 1.4 (1.1- 1.8) < 0.001 1.6 (1.3 – 2.0) 
Nodal Stage < 0.001 2.3 (1.9- 2.6) < 0.001 2.1 (1.9 – 2.4) 
ER status  0.010 0.7 (0.5- 0.9) 0.107 0.8 (0.6 – 1.1) 
ER=Estrogen receptor 
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Figure legend 
Figure 1: Association between histologic grade as assessed using digital slide imaging and traditional 
light microscope and breast cancer specific survival (BCSS) 
 
Figure 2: Association between histologic grade components as assessed using digital slide image 
traditional light microscope and breast cancer specific survival (BCSS); tubule formation: a & b, 
pleomorphism: c & d and mitotic scores: e & f. 
  
 
 
 
 
 
